Call for Abstract
3rd International Conference on Central Nervous System Disorders & Therapeutics, will be organized around the theme “Accelerate the Diagnosis, Prevention & Management of CNS Disorders”
CNS 2017 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in CNS 2017
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Central Nervous System may be defined as the system which is made up of the brain and spinal cord. The CNS is vulnerable to various disorders. CNS can be damaged by the following: Trauma, Infections, Degeneration, Structural defects, Tumours, Blood flow disruption, Autoimmune disorders etc.
Approximately 22 million patients suffer from various forms of dementia, two-thirds of which are related to Alzheimer’s. The WHO estimates the number of people suffering from multiple sclerosis worldwide at 2.5 million. As for schizophrenia, 1percent of the world’s population may be at risk.
- Track 1-1Cerebral edema
- Track 1-2Functional and structural disorders
- Track 1-3Fibromyalgia syndrome
- Track 1-4Arnold–Chiari malformation
- Track 1-5Bipolar Disorder
- Track 1-6Neuromyelitis optica
- Track 1-7Hydrocephalus
- Track 1-8CNS Neoplasia
- Track 1-9Spinal meningitis
- Track 1-10Holoprosencephaly
- Track 1-11CNS demyelinating disorders
- Track 1-12Development of Therapeutics for CNS Disorders
Neuropsychiatry focuses on psychiatric abnormalities like addictions, psychosis, and behavioural disorders like sleep disorders, mood disorders and eating disorders and correlate them to the neurological factors causing them.
- Track 2-1Psychosis
- Track 2-2Sleep disorders
- Track 2-3Mood disorders
- Track 2-4Eating disorders
Cerebral dysfunction may be focal or global. Focal dysfunction is caused by structural abnormalities and global dysfunction is caused by toxic-metabolic disorders and diffuses inflammation, vasculopathy, major trauma, or disseminated cancer; these diseases affect multiple dimensions of cerebral function.
Every year, an estimated 30,000 people in the United States experience a ruptured cerebral aneurysm and as many as 6percent may have an un-ruptured aneurysm.
- Track 3-1Cerebral hemorrhage
- Track 3-2Cerebral Ischemia
- Track 3-3Cerebral embolism
- Track 3-4Cerebral aneurysm
- Track 3-5Vascular malformation
- Track 3-6Risk factors for cerebrovascular diseases
- Track 3-7Epidemiology of cerebrovascular diseases
- Track 3-8Technological advances in vascular surgery
Neuronal Disorders may be defined as the disorders of the Brain, Spine and nerves that connect them. For example: Alzheimer's disease (AD) Epilepsy, Multiple sclerosis etc.
According to World Health Organization report- various types of neurodegenerative disorders affect millions of people around the world, including 25 million that suffer from Parkinson disease and 327 million who experience headaches and migraines.
- Track 4-1Brain Disorders
- Track 4-2Spinal Disorders
- Track 4-3Depression
- Track 4-4Attention Deficit Hyperactivity Disorder
- Track 4-5Multiple sclerosis and CNS demyelinating disorders
- Track 4-6Migraines and Headaches
- Track 4-7Schizophrenia
- Track 4-8Parkinsonism and Movement Disorders
- Track 4-9Dementia (AD)
- Track 4-10Prion disease
- Track 4-11Werdnig-Hoffmann Disease
- Track 4-12Neuroinflammation diseases
Neurosurgery may be defined as the surgical specialty that is concerned with the diagnosis and surgical treatment of the CNS and Peripheral Nervous System. It is also known as Neurological Surgery. It is performed by a physician called neurosurgeon. Based on nature of disorders or diseases, neurosurgeons provide operative and non-operative care. It helps to treat patients with brain tumour, head and spinal cord injury. Types of Neurosurgery include: I).Endovascular Neurosurgery, II).Oncological Neurosurgery III).Stereotactic Neurosurgery so on.
- Track 5-1Brain and Spinal surgery
- Track 5-2Tumour and metastatis
- Track 5-3Current Neurosurgery methods
- Track 5-4Anatomical and functional Neural circuits
- Track 5-5Neuropathological disorders
A Neuron communicates its electrical activity to other cells by releasing chemicals at the Junction of the two cells, that process is known as Neurochemical transmission. The chemical substances which transfer an electrical impulse from a nerve cell to its target cell are known as neurotransmitters.
- Track 6-1Dopamine
- Track 6-2Serotonin
- Track 6-3Neuropeptides
- Track 6-4Advances in astrocyte-neuron interactions in health and disease
- Track 6-5Drug interaction in various stages in neurotransmitters
Neuro-oncology defines the study of brain and spinal cord neoplasms, many of which are very dangerous and life-threatening. For example: glioma, glioblastoma multiforme, ependymoma, pontine glioma, and brain stem tumours etc. Most Commonly used treatments in neuro-oncology are Radiotherapy, Chemotherapy, Corticosteroids and Neurosurgical Interventions.
- Track 7-1Central Nervous System Cancers
- Track 7-2Neurobiology
- Track 7-3Metastatic tumors
- Track 7-4Clinical problems in neurooncology
- Track 7-5Neuroimaging and novel technologies
- Track 7-6Neuropathology
- Track 7-7Neurotoxicity and Neuroprotection
Cognitive neurology is a scientific study of neural mechanism underlying cognition. Cognitive Neurology is concerned with the diagnosis and treatment of diseases that affect memory and other ‘cognitive’ faculties (such as language, perception, planning-ability and social comportment). Cognitive neuroscience is at the intersection of psychology and neuroscience, but it also overlaps with physiological psychology, neuropsychology and cognitive psychology. This combines the theories of cognitive psychology & computational modelling with experimental data about the brain.
- Track 8-1Neurocognitive
- Track 8-2Evolution and Social Cognition
- Track 8-3Methods of cognitive neurosciencce
- Track 8-4Neurobehavioral and Cognitive Disorders
- Track 8-5Cognitive Genomics & behavioural genetics
The spinal cord refers as the main pathway for information connecting/transferring to the brain and peripheral nervous system. The spinal cord is also known as the large group of nerves which runs through the centre of the spinal cord and carries messages between the brain and the entire body. Spinal disorders may be seen in individuals irrespective of their age-Chiari malformation in infants to spinal stenosis in the elderly. The increase in population with spinal diseases has met with a leap in the advancements in diagnostic and treatment techniques. The commonly used tools in diagnosing spinal disorders are as follows: X rays, MRI, CT and DEA etc.
- Track 9-1Spinal Column Anatomy
- Track 9-2Levels of Injury
- Track 9-3Spinal Stenosis
- Track 9-4Sciatica
- Track 9-5Scoliosis Spine
- Track 9-6Spinal stroke
- Track 9-7Spine tumors
- Track 9-8Spinal Disorders Test
- Track 9-9Therapeutic approaches for spinal disorders
Transduction may be defined as the method that converts a sensory signal to an electrical signal to be processed in a specialized area in the brain.
The brain has it specific processing regions that are dedicated to processing the information which has previously passed through the thalamus for both motor and sensory signals. Growth Factor and Cytokine receptors plays very important role in the activation of the signal transduction.
- Track 10-1Neurophysiology
- Track 10-2Cell Signaling and Signal Transduction Pathways
- Track 10-3CNS Inflammation
Neurogenesis defines the process by which neurons are generated from neural stem cells and progenitor cells. Many different varieties of excitatory & inhibitory neurons are generated from different kinds of neural stem cells. The molecular and genetic factors influencing genesis of neuron notably include the Notch Signalling pathway, and many genes have been linked to Notch Signalling pathway regulation. It has been found to occur in two brain regions: the subventricular zone and the hippocampus.
- Track 11-1Neurogenesis
- Track 11-2Mechanisms of neurogenesis
- Track 11-3Neuronal Migration
- Track 11-4Neurons and Neuronal system
- Track 11-5Neural Development
- Track 11-6Adult neurogenesis
- Track 11-7Neuroplasticity
Neuro-pharmaceutics studies focuses on discovery of therapeutic targets, and then translating those discoveries into drug and therapy development. It is the largest potential growth sector of the pharmaceutical industry. However, this growth is blocked by the problem of the blood-brain barrier.
- Track 12-1Neuro Immune Pharmacology
- Track 12-2Psychopharmacology
- Track 12-3Antipsychotic drugs/ Neuroleptics
- Track 12-4Physical Therapy
- Track 12-5Surgical aggression and Anesthesia
- Track 12-6Clinical Pharmacists
- Track 12-7Avalilable therapeutics
- Track 12-8Neuroethics
- Track 12-9Future Aspects of Neuropharmacology
Clinical Aspects relating to or based on work done with real patients: of or relating to the medical treatment that is given to patients in hospitals, clinics, etc. It involves direct observation of the patient and based on or characterized by observable and diagnosable symptom. For example: Tumours of the Central Nervous System, Clinical Aspects of CNS Cysticercosis, Basic and Clinical Aspects of Malignant Melanoma etc.
- Track 13-1CNS tuberculosis
- Track 13-2Neuroimmunological Disorders
- Track 13-3Genetic testing for CNS disorders
- Track 13-4Remedies for CNS & Neurological Disorders
Neurology and Neuroscience is the special branch of medical Sciences that deals primarily with the disorders in the CNS. Neurophysiology defined as a union of both neurology and physiology and it studies the functioning of the nervous system.
- Track 14-1Case studies related to CNS disorders
- Track 14-2Case studies on Child Neurology
- Track 14-3Case studies on Neuroimmunology
- Track 14-4Case studies on Neurooncology
- Track 14-5Case reports on Brain Disorders
- Track 14-6Case studies on Cerebrovascular Cisorders
- Track 14-7Case studies and ethical issues
With an ever increasing average life expectancy, Neurological and CNS Disorders are becoming more prevalent in society. The economic and social costs of Neurological and CNS Disorders to society are huge. Many big pharmaceutical companies have moved away from CNS and Neurology research.
This meeting will give delegates an opportunity to gain additional knowledge and insights into the best practices in clinical trials, as well as addressing the challenges in CNS and Neurology research and by looking at the latest preclinical and clinical studies.
- Track 15-1 Clinical development in MS, PD and AD
- Track 15-2 Biomarkers implication in clinical trials
- Track 15-3 Current challenges in translational CNS research
- Track 15-4 Improvment of clinical trial development
- Track 15-5 Facilitating and establishing industry and academic partnering
- Track 15-6 Clinical trial safety and evaluation
- Track 15-7 New approaches for the design of clinical trials
The term Biomarker can be defined as a measurable indicator of some biological state or condition. A biomarker can also be known as a biological biomarker.
CNS 2016 conference focuses on the development of CNS biomarkers for drugs and diagnostics from Cerebrospinal fluid and Blood, as well as imaging approaches. Scientific data, updates and case studies in neurological and neurodegenerative diseases will be presented on disease areas such as Alzheimer's and Parkinson's.
- Track 16-1 Cerebrospinal fluid biomarkers
- Track 16-2 Neuroimaging enrichment biomarkers for CNS diseases
- Track 16-3 Biomarker Challenges in Rare Diseases
- Track 16-4 Technology case studies for CNS
- Track 16-5CNS drug development using biomarkers
The neuroscience perspective relates to the way that people act in terms of how they came to be. It deals with the scientific study of the nervous system and recognized as the branch of biology. On the other hand, neurology perspective deals with the branch of medicine dealing with the disorders of nervous system, diagnosis and treatment of all kind of diseases in the central nervous system and peripheral nervous system.
- Track 17-1Cognitive Neuroscience
- Track 17-2Clinical neurophysiology
- Track 17-3Computational Neuroscience
- Track 17-4Neuroimmunology
- Track 17-5Neuro Engineering
- Track 17-6Neurorehabilitation
- Track 17-7Neurological Nursing
The remarkable advances in animal models, genetics, biomarker development, and drug discovery have led to the development of novel neurotherapeutics. Innovative treatments include neurochemical and molecular targets, genes and epigenetic therapies, cognitive construct-based behavioral interventions, as well as neural circuitry-based therapies such as deep brain stimulation and magnetic stimulation.
- Track 18-1Neurotransmitters, neuromodulators, and neuroreceptors
- Track 18-2Centrally acting analgesics
- Track 18-3Blood brain barrier (BBB)
- Track 18-4Metabolism mediated drug-drug interactions
- Track 18-5Enzyme kinetics
- Track 18-6Role of drug metabolism in drug development
- Track 18-7Neurological Drug Targets